For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
How The No Surprises Act worsened the problem of surprise bills
Next week, Sen. Bill Cassidy (R-LA) will convene a roundtable to discuss adjustments to the 2020 No Surprises Act, which has come under…
National Review
Prescription Drugs Save Lives at a (Mostly) Reasonable Cost
Prescription drugs are an extraordinary lifesaving and life-enhancing technology, so integrated into our daily lives that, nowadays, we perhaps take them for granted. Headlines and…
News Release
FDA deserves credit for approval pancreatic cancer drug
The FDA on August 26 approved a new breakthrough drug to treat pancreatic cancer. CEI Senior Fellow and Economist Jeremy Nighohossian praised…
Search Posts
Letters
CEI Joins American Consumer Institute in Support for the Biosimilar Red Tape Elimination Act: A Step Toward Lower Costs and Greater Access
Dear Chairman Cassidy, Chairman Guthrie, Ranking Member Pallone, Ranking Member Sanders: We, the undersigned consumer, free-market, and taxpayer organizations, write to thank you…
Blog
Free the Economy podcast: Alcohol labels and warnings with David Clement
In this week’s episode we cover housing abundance in California, the meaning of a market economy, union privileges for government…
News Release
Senate Big Beautiful Bill Contains Needed Medicaid Reforms
The Senate today voted 51 to 50 to pass the Reconciliation package known as the “One Big Beautiful Bill,” following House passage in…
News Release
Senate Parliamentarian Eliminates Medicaid Reform Provisions, Leaving Costs/Problems Intact
The Senate’s parliamentarian has determined that many of the Medicaid provisions in the One Big Beautiful Bill cannot be passed with simple majority vote…
Blog
FDA can’t stomach fluoride and doesn’t want you to, either
On May 13, the Food and Drug Administration (FDA) announced that it would begin a process intended to exclude ingestible prescription fluoride products…
Blog
Free the Economy podcast: Drug costs and benefits with Sally Pipes
In this week’s episode we cover reforms to the Endangered Species Act, attacks on US tech firms, nuclear power…